Reform of the Veterinary Medicines Act
2025年10月13日
Daniel Tietjen is member of the Practice Area Patents Technology & Life Sciences and the Life Sciences & Healthcare Industry Group. His focus is on litigation and legal advice to national and international companies, particularly in all areas of pharmaceutical law, medical device law, unfair competition law and intellectual property law including trademark law.
最新新闻和观点
Synapse - Europe's approach to supply chain issues for medicines and medical devices
点击此处了解更多
Comparison of national measures to protect the supply of medicines and medical devices
Our international team has developed a practical guide that allows users to navigate different European jurisdictions, identifying medicines subject to supply restrictions, and understand manufacturers' obligations during shortages or product withdrawals.
2025年10月1日
5 / 5 观点
酒店与休闲
点击此处了解更多
Rx bonus decision by the German Federal Court of Justice (BGH): German drug pricing law not applicable to EU mail-order pharmacies
2025年9月26日
Briefing
